BAL-19403

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameBAL-19403
Drug Alias NameBAL-19403
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitorsPhosphodiesterase 3 inhibitorsPhosphodieterase 4 inhibitors
Targets50S ribosomal subunitPhosphodiesterase 3Phosphodieterase 4
Therapy Area/IndicationsAcne VulgarisBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBasilea Pharmaceutica
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBasilea Pharmaceutica
Active IndicationsN/A
Inactive IndicationsAcne VulgarisBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A